Advertisement
Screener

ZIMMER BIOMET HOLDINGS, INC. (ZBH) Goodwill, Foreign Currency Translation Gain (Loss)

1.7 / 5 stars · 36/109 Roast Me

ZIMMER BIOMET HOLDINGS, INC. Goodwill, Foreign Currency Translation Gain (Loss)

ZIMMER BIOMET HOLDINGS, INC. (ZBH) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$21.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Other Income

us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-05

  • ZIMMER BIOMET HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$6.40M.
  • ZIMMER BIOMET HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$14.80M.
  • ZIMMER BIOMET HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was -$3.50M.
  • ZIMMER BIOMET HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was -$400.00K.
  • ZIMMER BIOMET HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2025 was $110.60M.
  • ZIMMER BIOMET HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$68.00M, a 391.85% decline from fiscal 2023.
  • ZIMMER BIOMET HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $23.30M.
  • ZIMMER BIOMET HOLDINGS, INC. goodwill, foreign currency translation gain (loss) for fiscal 2021 was -$89.00M.
Period endGoodwill, Foreign Currency Translation Gain (Loss) 3 monthGoodwill, Foreign Currency Translation Gain (Loss) 6 monthGoodwill, Foreign Currency Translation Gain (Loss) 9 monthGoodwill, Foreign Currency Translation Gain (Loss) 12 monthGoodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed
2026-06-30-$6.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$21.20M
10-Q · filed 2026-08-05
-$24.70M
derived: sum of 3 quarters · filed 2026-08-05
-$25.10M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$14.80M
10-Q · filed 2026-05-01
-$18.30M
derived: sum of 2 quarters · filed 2026-05-01
-$18.70M
derived: sum of 3 quarters · filed 2026-05-01
2025-12-31-$3.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
-$3.90M
derived: sum of 2 quarters · filed 2026-02-20
$110.60M
10-K · filed 2026-02-20
2025-09-30-$400.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$114.10M
10-Q · filed 2025-11-05
2025-06-30$114.50M
10-Q · filed 2025-08-07
2024-12-31-$68.00M
10-K · filed 2026-02-20
2023-12-31$23.30M
10-K · filed 2025-02-25
2022-12-31-$98.60M
8-K · filed 2024-08-07
2021-12-31-$14.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
-$43.80M
derived: sum of 2 quarters · filed 2023-02-24
-$32.40M
derived: sum of 3 quarters · filed 2023-02-24
-$89.00M
10-K · filed 2023-02-24
-$94.90M
10-K · filed 2022-02-25
2021-09-30-$29.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
-$17.70M
derived: sum of 2 quarters · filed 2021-11-04
-$74.30M
10-Q · filed 2021-11-04
-$18.80M
derived: sum of 4 quarters · filed 2022-06-22
2021-06-30$11.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
-$45.20M
10-Q · filed 2021-08-03
$10.30M
derived: sum of 3 quarters · filed 2022-06-22
$66.80M
derived: sum of 4 quarters · filed 2022-06-22
2021-03-31-$56.60M
10-Q · filed 2021-05-04
-$1.10M
derived: sum of 2 quarters · filed 2022-06-22
$55.40M
derived: sum of 3 quarters · filed 2022-06-22
$86.60M
derived: sum of 4 quarters · filed 2022-06-22
2020-12-31$55.50M
derived: 8-K 12 month − 10-Q 9 month · filed 2022-06-22
$112.00M
derived: sum of 2 quarters · filed 2022-06-22
$143.20M
derived: sum of 3 quarters · filed 2022-06-22
$106.40M
8-K · filed 2022-06-22
$111.90M
10-K · filed 2021-02-22
2020-09-30$56.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$87.70M
derived: sum of 2 quarters · filed 2020-11-06
$50.90M
10-Q · filed 2020-11-06
2020-06-30$31.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
-$5.60M
10-Q · filed 2020-08-05
2020-03-31-$36.80M
10-Q · filed 2020-05-11
2019-12-31-$19.70M
10-K · filed 2021-02-22
2018-12-31-$98.10M
10-K · filed 2020-02-21
2017-12-31$58.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$136.00M
derived: sum of 2 quarters · filed 2019-02-26
$249.70M
derived: sum of 3 quarters · filed 2019-02-26
$310.80M
10-K · filed 2019-02-26
2017-09-30$77.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
$191.10M
derived: sum of 2 quarters · filed 2017-11-06
$252.20M
10-Q · filed 2017-11-06
$111.10M
derived: sum of 4 quarters · filed 2018-02-27
2017-06-30$113.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$174.80M
10-Q · filed 2017-08-08
$33.70M
derived: sum of 3 quarters · filed 2018-02-27
$64.30M
derived: sum of 4 quarters · filed 2018-02-27
2017-03-31$61.10M
10-Q · filed 2017-05-09
-$80.00M
derived: sum of 2 quarters · filed 2018-02-27
-$49.40M
derived: sum of 3 quarters · filed 2018-02-27
-$71.30M
derived: sum of 4 quarters · filed 2018-02-27
2016-12-31-$141.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
-$110.50M
derived: sum of 2 quarters · filed 2018-02-27
-$132.40M
derived: sum of 3 quarters · filed 2018-02-27
-$67.00M
10-K · filed 2018-02-27
2016-09-30$30.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
$8.70M
derived: sum of 2 quarters · filed 2016-11-08
$74.10M
10-Q · filed 2016-11-08
2016-06-30-$21.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$43.50M
10-Q · filed 2016-08-08
2016-03-31$65.40M
10-Q · filed 2016-05-10
2015-12-31-$153.90M
10-K · filed 2017-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
STERIS plc (STE)Ireland$20.343B25.49
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B